G.E. Staddon

Guidelines on oral anticoagulation: third edition

Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

Risk Factors for Venous Thromboembolism

Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.

The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

Pharmacology and Management of the Vitamin K Antagonists

Boron Neutron Capture Therapy of Brain Tumors: Past History, Current Status, and Future Potential

Prevention of Deep Vein Thrombosis after Elective Hip Surgery

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Role of insulin in regulation of lipoprotein metabolism in diabetes

Abnormalities of the Left Temporal Lobe and Thought Disorder in Schizophrenia

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis

Standardisation of spirometry

Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin

The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Thromboprophylaxis and death after total hip replacement

Translation of new cancer treatments from pet dogs to humans

Aminoglycoside antibiotics induce bacterial biofilm formation

Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer

Oral Anticoagulants

A review of postgastrectomy bone disease

Prevention of Venous Thromboembolism

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

A review of the biomaterials technologies for infection-resistant surfaces

Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip Replacement

Optical properties of biological tissues: a review

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Prevention of Venous Thromboembolism

Venous Thromboembolism Associated With Hip and Knee Arthroplasty: Current Prophylactic Practices and Outcomes

The Pharmacology and Management of the Vitamin K Antagonists

Antithrombotic Therapy for Venous Thromboembolic Disease

Ghrelin: Structure and Function

Guidelines for the Prevention of Intravascular Catheter-related Infections

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis

Identification of Novel Tumor-Associated Cell Surface Sialoglycoproteins in Human Glioblastoma Tumors Using Quantitative Proteomics

Venous Thromboembolism

Guidelines for the Early Management of Adults With Ischemic Stroke

Femoral vein thrombosis and total hip replacement.

Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors

Impact of the patient population on the risk for heparin-induced thrombocytopenia

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Maturation of the hemostatic system during childhood

THROMBOPROPHYLAXIS AND DEATH AFTER TOTAL HIP REPLACEMENT

Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity

Prevention of Venous Thromboembolism

Accuracy of ventricular volume estimation.

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Effects of vasodilators on pulmonary hemodynamics and gas exchange in left ventricular failure

Guidelines for the Primary Prevention of Stroke

A venous foot pump reduces thrombosis after total hip replacement

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Effects of profound hypotension on cerebral blood flow during surgery for intracranial aneurysms

Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

LOWER RISK OF THROMBOEMBOLIC DISEASE AFTER TOTAL HIP REPLACEMENT WITH NON-CEMENTED THAN WITH CEMENTED PROSTHESES

A Meta-analysis of Methods to Prevent Venous Thromboembolism Following Total Hip Replacement

Venous thrombosis after elective hip replacement—the influence of preventive intermittent calf compression and of surgical technique

The Risk of Determining Risk with Multivariable Models

Guidelines for Adult Stroke Rehabilitation and Recovery

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

The Chemistry of Neutron Capture Therapy

Prevention of Postoperative Venous Thrombosis: A Randomized Trial Comparing Unfractionated Heparin with Low Molecular Weight Heparin in Patients Undergoing Total Hip Replacement

Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage

The natural history and aetiology of deep vein thrombosis after total hip replacement

Low-Molecular-Weight Heparins

Role of Insulin Resistance in Human Disease

Development and validation of a predictive model for chemotherapy-associated thrombosis

Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or Dextran 70

A Cost-effectiveness Analysis of Prophylaxis Against Deep-Vein Thrombosis in Major Orthopedic Surgery

Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip Replacement

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy

Pulmonary Vasodilator Responses to Nitroprusside and Nitroglycerin in the Dog

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis

Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.

Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis

Effect of Size and Disease on Estimated Deposition of Drugs Administered Using Jet Nebulization in Children With Cystic Fibrosis

Chemical Glycoproteomics

Complexity and contradiction in clinical trial research

Tissue blood content in anaesthetised sheep and horses

The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis

FAILURE OF LOW-DOSE HEPARIN TO PREVENT DEEP-VEIN THROMBOSIS AFTER HIP-REPLACEMENT ARTHROPLASTY

Radioimmunolocalisation of human brain tumours: Biodistribution of radiolabelled monoclonal antibody UJ13A

THE EFFECT OF WHOLE-BONE EXTRACT ON ⁴⁷Ca ABSORPTION IN THE ELDERLY

CEREBRAL BLOOD FLOW AND METABOLISM DURING HYPOTENSION INDUCED WITH SODIUM NITROPRUSSIDE

Lecithin-cholesterol acyltransferase activity in diabetes mellitus and the effect of insulin on these cases

Efficacy of fixed minidose warfarin prophylaxis in total hip replacement.

Transventricular Absorption and Isotope Ventriculography